Ose Immunotherapeutics will conduct a clinical trial involving up to 400 patients for an experimental COVID-19 vaccine it hopes can further help fight the global pandemic. This vaccine wouldn’t be available until 2022, assuming the investigational product...
T-Cells
Atlantic Health Research Leads Study Demonstrating the Potential of T Cell-based Vaccines Targeting COVID-19
Atlantic Health System, a prominent New Jersey-based health system, took on enormous challenges during COVID-19 as its proximity to epicenter in New York City. Demonstrating heroism, steadfast commitment to patients, and innovative responses to seemingly one crisis...
Cardiff University Researchers Make Universal Cancer Treatment Involving Immunotherapy
Researchers at Cardiff University’s School of Medicine have discovered a new method for killing an array of cancers such as prostate, breast, lung, and others. The group of investigators, based in Wales, has developed a process that utilizes T-cell receptors within...
Penn Breakthrough as CRISPR-Edited Immune Cells Survive & Thrive After Infusion in Patients
Researchers from the University of Pennsylvania’s Abramson Cancer Center (Penn) have concluded, based on research, that genetically edited immune cells can persist, thrive, and function months after a cancer patient received them. They have demonstrated that cells...
Children’s National Hospital & NIAID Share Early Study Findings on Tailored T-Cells for Rare Viruses
The Center for Cancer and Immunology Research at Children’s National Hospital and the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) formed a partnership in 2017 to develop and conduct collaborative clinical research studies focused on young...
Duke Research Identify Enzyme That Suppresses Immune System in Breast Cancer
Duke University preclinical researchers have been able to inhibit a key enzyme in mice triggering an immune attack on the breast cancer tumor. Duke University researchers involved with preclinical activity have identified an enzyme in cells involved in regulating the...
Ludwig Cancer Research Identify Biomarkers for Potential Cancer Immunotherapy
Ludwig Cancer Research investigators have deciphered a complex molecular relationship between cancer and immune cells. Evidencing the vital role of T-cell invasion in tumors that kill cancers, the findings can be used to inform the design of novel cell-based and...
University of Texas, Austin Capture First Ever Video of Body’s Safety Test for T Cells
University of Texas at Austin immunologists have captured on video for the first time what happens when T-cells—(the contract killers of the immune system, responsible for wiping out bacteria and viruses)—undergo a type of assassin training program before they are...